DOPAMINE TREATMENT FOR SEVERE OVARIAN HYPERSTIMULATION SYNDROME

被引：61

作者：

FERRARETTI, AP

GIANAROLI, L

DIOTALLEVI, L

FESTI, C

TROUNSON, A

机构：

[1] IVF Centre, 40136 Bologna, Via Castiglione

[2] Clinique de Stérilité et d'Endocrinologie Gynécologique, Université de Genéve, Genèeve,1211, 32, Boulevard de le Cluse

[3] Centre for Early Human Development, Monash Medical Centre, Clayton, VIC 3168

来源：

HUMAN REPRODUCTION | 1992年 / 7卷 / 02期

关键词：

DOPAMINE; OVARIAN HYPERSTIMULATION SYNDROME;

D O I：

10.1093/oxfordjournals.humrep.a137613

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Seven oliguric patients with severe ovarian hyperstimulation syndrome following gonadotrophin treatment for in-vitro fertilization or gamete intra-Fallopian transfer, were treated with low doses of dopamine by peripheral infusion. Five patients were pregnant. The rationale for this therapeutic approach was to increase renal blood flow and glomerular filtration. In addition to dopamine, fluid intake was restricted to 500 ml/day and a protein and salt-rich diet was provided in order to increase serum osmolarity. Within 24-48 h from the beginning of the dopamine treatment, the syndrome started to regress in all cases. No adverse maternal or fetal effects occurred. We conclude that dopamine therapy may constitute a major advance towards the management of severe ovarian hyperstimulation syndrome.

引用

页码：180 / 183

页数：4

共 12 条

[1]

Felder R.A., Blecher M., Eisner G.M., Cortical tubular and glomerular dopamine receptors in the rat kidney, Am. J. Physiol., 246, pp. 557-561, (1984)

[2]

Gianaroli L., Ferraretti A.P., Seracchioli R., Trounson A.O., Flamigni C., Bovicelli L., The successful use of human amniotic fluid for mouse embryo culture and human in vitro fertilization, embryo culture and transfer. Fertil, Steril., 46, pp. 907-913, (1986)

[3]

Haning R.U., Strawn E.V., Nolten W.E., Pathophysiology of the ovarian hyperstimulationsyndrome.Obstet, Gynecol., 66, pp. 220-224, (1985)

[4]

Kirshan B., Lee W., Mauer M.B., Cotton D.B., Effects of low-dose dopamine therapy in the oliguric patient with preeclampsia, Am. J. Obstet. Gynecol., 159, pp. 604-607, (1988)

[5]

Knox G.E., Antihistamine blockade of the ovarian hyperstimulation syndrome, Am. J. Obstet. Gynecol., 118, pp. 992-994, (1974)

[6]

Navot D., Margalioth E.J., Laufer N., Birkenfeld A., Relou A., Rosier A., Schenker J.G., Direct correlation between plasma renin activity and severity of the ovarian hyperstimulation syndrome. Fertil, Steril., 40, pp. 57-61, (1987)

[7]

Ryley N.G., Forman R., Barlow D., Fleming K.A., Trowell J.M., Liver abnormality in ovarian hyperstimulation syndrome. Hum, Reprod., 5, pp. 938-943, (1990)

[8]

Schenker J.G., Polishuk W.Z., Ovarian hyperstimulationsyndrome.Obstet, Gynecol., 46, pp. 23-28, (1975)

[9]

Schenker J.G., Polischuk W.Z., Role of prostaglandins in ovarian hyperstimulation syndrome. Obstet. Gynecol, Surv., 31, pp. 742-745, (1976)

[10]

Schenker J.G., Weinstein D., Ovarian hyperstimulationsyndrome: A current survey. Fertil, Steal., 30, pp. 255-268, (1978)

← 1 2 →